Literature DB >> 2656978

Antibodies to Bacteroides gingivalis in patients with treated and untreated periodontal disease.

P A Murray1, D A Burstein, J R Winkler.   

Abstract

It is proposed that the development of periodontal disease is associated with rising levels of serum and gingival crevice fluid (GCF) IgG antibodies to specific organisms, while treatment of periodontal disease is associated with a decline in specific IgG antibodies. This study examined the immune response to Bacteroides gingivalis, a suspected periodontal pathogen, in serum and GCF of patients with adult periodontitis. Three groups of subjects were studied: (1) patients with untreated adult periodontitis, (2) patients with treated adult periodontitis, and (3) patients with gingivitis (controls). An enzyme-linked immunosorbent assay was employed using whole formalinized B. gingivalis (ATCC 33277) as antigen. Results showed that the untreated adult periodontitis patients had a humoral immune response to B. gingivalis, producing significantly higher serum levels of IgG antibody to that organism than did patients with treated adult periodontitis (p less than or equal to 0.01) or gingivitis (p less than or equal to 0.005). The untreated patients also demonstrated a local immune response to B. gingivalis in that their GCF levels of IgG antibody to that organism were also significantly higher than levels in treated adult periodontitis patients (p less than or equal to 0.005) and gingivitis patients (p less than or equal to 0.001). These results are consistent with reports by other investigators. However, ratios of GCF antibody to serum antibody in the untreated adult periodontitis group were not significantly higher than ratios in the other two groups.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2656978     DOI: 10.1902/jop.1989.60.2.96

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  6 in total

Review 1.  Periodontal disease immunology: 'double indemnity' in protecting the host.

Authors:  Jeffrey L Ebersole; Dolphus R Dawson; Lorri A Morford; Rebecca Peyyala; Craig S Miller; Octavio A Gonzaléz
Journal:  Periodontol 2000       Date:  2013-06       Impact factor: 7.589

2.  B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease.

Authors:  Toshihisa Kawai; Takashi Matsuyama; Yoshitaka Hosokawa; Seicho Makihira; Makoto Seki; Nadeem Y Karimbux; Reginaldo B Goncalves; Paloma Valverde; Serge Dibart; Yi-Ping Li; Leticia A Miranda; Cory W O Ernst; Yuichi Izumi; Martin A Taubman
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

3.  Hydrolysis of epithelial junctional proteins by Porphyromonas gingivalis gingipains.

Authors:  Jannet Katz; Qiu-Bo Yang; Ping Zhang; Jan Potempa; James Travis; Suzanne M Michalek; Daniel F Balkovetz
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

4.  Initial serum antibody titer to Porphyromonas gingivalis influences development of antibody avidity and success of therapy for chronic periodontitis.

Authors:  J Mooney; E Adonogianaki; M P Riggio; K Takahashi; A Haerian; D F Kinane
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

5.  Humoral response to Porphyromonas (Bacteroides) gingivalis in rats: time course and T-cell dependence.

Authors:  J Katz; R M Leary; D C Ward; C C Harmon; S M Michalek
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

6.  Heterogeneity of human serum antibody responses to P. gingivalis in periodontitis: Effects of age, race/ethnicity, and sex.

Authors:  J L Ebersole; M Al-Sabbagh; D R Dawson
Journal:  Immunol Lett       Date:  2019-12-18       Impact factor: 3.685

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.